Clinical Evidence for Targeting NAD Therapeutically
Nicotinamide adenine dinucleotide (NAD) pharmacology is a promising class of treatments for age-related conditions that are likely to have a favorable side effect profile for human use, given the widespread use of the NAD precursor vitamin B3 supplements. However, despite several decades of active i...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2020-09-01
|
| Серии: | Pharmaceuticals |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1424-8247/13/9/247 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|